Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01591408 · ClinicalTrials.gov registry record · NA
EEG Biofeedback Therapy as an Adjunct Treatment for PTSD
A NA study, sponsored by United States Naval Medical Center, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01591408 is a NA study that has completed, run by United States Naval Medical Center, San Diego. The registered enrollment target is 68 participants.
The verdict
NCT01591408, a NA study, has completed, sponsored by United States Naval Medical Center, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The proposed study, "Placebo-controlled study of EEG biofeedback therapy as an adjunct treatment for PTSD, evaluating symptoms and EEG dynamics", will investigate the brain dynamics associated with PTSD symptom reduction associated with EEG biofeedback therapy or sham EEG biofeedback in addition to treatment as usual at the Naval Medical Center, San Diego (NMCSD) OASIS program. EEG biofeedback treatment protocols for PTSD and other disorders have been developed and honed by private practice clinicians over the past 25 years, during which EEG biofeedback has become an increasingly popular adjunct therapy. The reported success of EEG biofeedback as a non-drug intervention with lasting efficacy warrants a clinical study investigating not only symptom reduction, but also the underlying neurobiological mechanism. To this end, we propose a study using high density EEG recordings before and after treatment for PTSD symptoms to determine which brain activities correlate with reported symptom changes. The proposed study could expand treatment alternatives for servicemen with PTSD. If EEG biofeedback is shown to improve symptom reduction over the placebo controlled condition, it would offer a non-pharmacological intervention that would avoid undesirable side effects, and accelerate recovery compared with the current standard of care.
Interventions
- DEVICE EEG biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01591408
The ClinicalTrials.gov registry entry for NCT01591408 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Naval Medical Center, San Diego, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EEG biofeedback is the first listed.
NCT01591408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01591408 about?
NCT01591408 is a clinical study titled "EEG Biofeedback Therapy as an Adjunct Treatment for PTSD". The proposed study, "Placebo-controlled study of EEG biofeedback therapy as an adjunct treatment for PTSD, evaluating symptoms and EEG dynamics", will investigate the brain dynamics associated with PTSD symptom reduction associated with EEG biofeedback therapy or sham EEG biofeedback in addition to ...
What is the current status of trial NCT01591408?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2012-05. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01591408?
The interventions under investigation include: EEG biofeedback (DEVICE).
Who is sponsoring clinical trial NCT01591408?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.